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Abstract
Background: Onchocerciasis is the world’s second leading infectious cause of blindness. Its control is currently
hampered by the lack of a macrofilaricidal drug and by severe adverse events observed when the lone
recommended microfilaricide, ivermectin is administered to individuals co-infected with Loa loa. Therefore, there is
the need for a safe and effective macrofilaricidal drug that will be able to cure the infection and break transmission
cycles, or at least, an alternative microfilaricide that does not kill L. loa microfilariae (mf).
Methods: Fourteen extracts from two medicinal plants, Tragia benthami and Piper umbellatum were screened
in vitro against Onchocerca ochengi parasite and L. loa mf. Activities of extracts on male worms and microfilariae
were assessed by motility reduction, while MTT/Formazan assay was used to assess biochemically the death of
female worms. Cytotoxicity and acute toxicity of active extracts were tested on monkey kidney cells and Balb/c
mice, respectively.
Results: At 500 μg/mL, all extracts showed 100 % activity on Onchocerca ochengi males and microfilariae, while 9
showed 100 % activity on female worms. The methylene chloride extract of Piper umbellatum leaves was the most
active on adult male and female worms (IC50s: 16.63 μg/mL and 35.65 μg/mL, respectively). The three most active
extracts on Onchocerca ochengi females were also highly active on Loa loa microfilariae, with IC50s of 35.12 - 13.
9 μg/mL. Active extracts were generally more toxic to the worms than to cells and showed no acute toxicity to
Balb/c mice. Phytochemical screening revealed the presence of saponins, steroids, tannins and flavanoids in the
promising extracts.
Conclusions: These results unfold potential sources of novel anti-Onchocerca lead compounds and validate the
traditional use of the plants in onchocerciasis treatment.
Keywords: Onchocerciasis, Loa loa, Tragia benthami, Piper umbellatum
Abbreviations: CCM, Complete culture medium; DMSO, Dimethyl sulfoxide; ICM, Incomplete culture medium; L.
loa, Loa loa; Mf, Microfilariae; O. ochengi, Onchocerca ochengi; O. volvulus, Onchocerca volvulus; PULhex, Hexane
extract of Piper unbellatum leaves; PULmc, Methylene chloride extract of Piper unbellatum leaves; PULmet, Methanol
extract of Piper unbellatum leaves; PURhex, Hexane extract of Piper unbellatum roots; PURmc, Methylene chloride
extract of Piper unbellatum roots; PURmet, Methanol extract of Piper unbellatum roots; PUShex, Hexane extract of
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TBLhex, Hexane extract of Tragia benthami leaves; TBLmc, Methylene chloride extract of Tragia benthami leaves;
TBLmet, Methanol extract of Tragia benthami leaves; TBRhex, Methanol extract of Tragia benthami roots;
TBRmc, Methylene chloride extract of Tragia benthami roots; TBRmet, Methanol extract of Tragia benthami roots;
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Background
Human onchocerciasis also known as river blindness is a
neglected tropical disease caused by the filarial worm,
Onchocerca volvulus. It is the world’s second leading in-
fectious cause of blindness, transmitted by black flies of
genus Simulium [1]. An estimated 37 million people in
tropical countries are infected with the parasite, with ap-
proximately 99 % of all cases in Africa [1]. Adult worms
of O. volvulus live in subcutaneous nodules for more
than 14 years and produce millions of microfilariae (mf),
which parasitize skin and eye tissues, resulting often in
debilitating pathologies, which include blindness [2]. On
the other hand, loasis, caused by the filarial worm, Loa
loa, prevalent mainly in the rain forests of West and
Central Africa is not as severe as the other filariasis and
is consequently less well studied [3, 4]. L. loa and O. vol-
vulus are often co-endemic, infecting the same individ-
uals, rendering the control of onchocerciasis somewhat
difficult.
Current control measures for onchocerciasis rely heav-
ily on the community directed treatment with the only
recommended drug, ivermectin. However, the use of this
drug is limited in areas of L. loa co-endemicity due to
severe adverse events observed in people with high L.
loa microfilaraemia because of the good activity of the
drug on the L.loa mf in blood [5]. Moreover, ivermectin
is only microfilaricidal and requires continuous delivery
for at least 14 years (which corresponds to the life span
of the adult worm) to interrupt transmission [5]. Lastly,
parasites isolated from communities with sub-optimal
responses to annual treatment in Ghana showed genetic
changes observed with resistance to ivermectin in other
nematodes [6]. Therefore, there is the need for a safe
and effective macrofilaricidal drug against onchocerciasis
that will be able to cure the infection and break trans-
mission cycles, or at least, an alternative microfilaricide
that does not kill L. loa mf. Such a drug has been diffi-
cult to come by, especially considering for-profit
pharmaceutical companies, requiring alternative strat-
egies to aid its discovery and development.
Natural medicines, including medicinal plants, have
played a very significant role in the health care of rural
populations in Africa and other developing countries [7].
The majority of drugs active against infectious agents
are in fact, derived from natural products [8]. For ex-
ample, ivermectin itself is isolated from Streptomyces
avermitilis [9], and the malaria drug, artemisinin, de-
rived from the medicinal plant, Artemisia annua [10].
Previous studies have revealed the filaricidal effect of
some Cameroonian medicinal plants [11–13]. Many of
the studies have been based on the bovine derived Onch-
ocerca ochengi (O. ochengi), currently known to be the
closest relative and most suitable model of Onchocerca
volvulus, which is difficult and expensive to obtain from
humans [14]. The present study was therefore, carried
out to assess and potentially exploit the acclaimed anti-
filarial properties of Piper umbellatum L and Tragia
benthami B, two plants used in the traditional treatment
of onchocerciasis in Cameroon, on O. ochengi and L.
loa. T. benthami is a herbaceous climber or trailer, with
stinging hairs, of the family Euphobiaceae found in West
Africa, mostly Cameroon, along the banks of fast run-
ning streams. Studies have shown the antibactericidal,
antifungal, antipyretic and analgesic properties of ethyl
acetate and ethanol extracts of a related Tragia species
[15, 16]. P. umbellatum, on the other hand, is a tropical
shrub of the family Piperaceae with many nutritional
and medicinal values in different parts of Nigeria. Its ex-
tracts have been demonstrated to exhibit contraceptive
and bactericidal activities [17–19].
Methods
Collection, identification and processing of plants
The plants, P. umbellatum (voucher number 19813) and
T. benthami (voucher number 33628) were harvested in
the village of Santa Mbei in the North West Region of
Cameroon, based on ethnobotanical and pharmaco-
logical information. Voucher specimens were taken to
the National Herbarium of Cameroon, Yaoundé, where
they were authenticated by a botanist and voucher num-
bers assigned to them. The leaves and roots of T.
benthami and the leaves, roots and seeds of P. umbella-
tum were air dried to constant weight and then ground
to fine powder.
Preparation of crude extracts and stock solutions
Each powder was macerated for 48 h, sequentially, three
times per solvent, in hexane, methylene chloride, and
then methanol. The filtrates were concentrated using a
rotary evaporator (BUCHI Rotavapor R-200, Switzerland)
at the boiling points of the solvents. Each crude extract
was recovered with a small volume of methylene chloride
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and left on the shelf for 72 h for any residual solvent to
evaporate. The dried extracts were then weighed, and
the percentage yield calculated. Stock solutions of
25 mg/mL were also prepared from each extract in di-
methyl sulfoxide (DMSO, solvent grade >99.8 %, from
Sigma-Aldrich, Germany) and kept at −20 °C until tested
on worms and larvae.
Isolation and screens on Onchocerca ochengi adult worms
Isolation of O. ochengi adult worms (macrofilariae)
Worms were isolated by the method described by Cho-
Ngwa et al. [20]. Briefly, fresh pieces of umbilical cattle
skin with palpable nodules bought from slaughter houses
in Douala and Buea, Cameroon, were thoroughly washed
with soap and water, and the inner and outer surfaces
sterilized with 70 % ethanol which was allowed to evap-
orate in a lamina flow sterile hood. Nodules were care-
fully excised, and the recovered worm masses
submerged in complete culture medium (CCM, which is
RPMI 1640 with NaHCO3 and supplemented with
25 mM HEPES, 0.3 g γ-irradiated L-glutamine powder,
5 % newborn calf serum, 200 units/mL penicillin,
200 μg/mL streptomycin and 0.25 μg/mL amphotericin
B; pH 7.4) in 24-well culture plates (NUNC, USA). The
plates containing the worms were incubated overnight at
37 °C under an atmosphere of 5 % CO2 in humidified air
(in a HERACELL-150i CO2 incubator, USA). Thereafter,
the viability of worms and sterility of cultures were eval-
uated using an inverted microscope (Nikon Eclipse
TS100, China) prior to drug testing in primary and sec-
ondary screens.
Primary screens on Onchocerca ochengi adult worms
The primary screen was done in order to eliminate in-
active extracts. The worms were treated in quadrupli-
cates with either an extract at 500 μg/ml in CCM, or
auranofin at10 μM (serving as positive control) [21] or
2 % DMSO (negative control), and incubated for 5 days
at 37 °C in 5 % CO2 atmosphere, and their viabilities
assessed. The 2 % DMSO was shown to be safe for
worms in our previous studies [11–13].
Adult male worm viability was assessed through evalu-
ation of worm motility using an inverted microscope.
Activity scores ranged from 100 % (complete inhibition
of motility), 75 % (only head or tail of worm shaking oc-
casionally), 50 % (whole worm motile, but sluggishly),
25 % (only little change in motility), to 0 % (no observ-
able change in motility).
Activity of extracts on female worms was assessed bio-
chemically, by visual estimation of percentage inhibition
of formazan (blue colour) formation following incuba-
tion of the nodules in 500 μl of 0.5 mg/ml MTT (3-(4, 5
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide,
from Sigma) for 30 min [11, 12]. Activity scores assigned
ranged from 100 % parasite killing (no blue formazan
coloration seen), 90 %, 75 %, 50 %, 25 %, to 0 % (entire
worm appears blue as in negative control).
An extract was considered active if there was ≥ 90 %
inhibition of male worm motility or of formazan forma-
tion; moderately active if there was a 50–89 % inhibition
of male worm motility or of formazan formation and in-
active if there was a < 50 % inhibition of male worm mo-
tility or of formazan formation. All experiments were
repeated once prior to the secondary screens.
Isolation of and screens with Onchocerca ochengi
microfilariae
Preparation of mammalian cells
LLC-MK2 obtained from American Type Culture Col-
lection (ATCC, Virginia, USA) were proliferated in CCM
at 37 °C under an atmosphere of 5 % CO2 in humified
air. The cells were grown in 96-well plates until they be-
came fully confluent, and served as feeder layers for the
microfilariae (mf) assays. The cells were also used for
cytotoxicity assessment of the extracts [13].
Isolation of Onchocerca ochengi microfilariae
This was by the method of Cho-Ngwa et al. [11] with
slight modifications. Briefly, umbilical cattle skin pieces
containing palpable nodules were obtained from the ab-
attoir, cleaned, carefully shaved, and sterilized with 70 %
ethanol. Skin slivers were obtained and incubated for 4–
6 h at room temperature in CCM and the emerged and
highly motile O. ochengi mf were concentrated by centri-
fugation (400×g, 10 min). The mf were re-suspended in
CCM and distributed into wells (about 15 mf/100 μL of
CCM/well) of the 96-well plates containing the LLC-
MK2 cell layer, and their viability and sterility ascer-
tained for 24 h prior to addition of extracts.
Primary screens on O. ochengi mf
This was done as previously described [11]. Primary
screens were done at 500 μg/mL in duplicates, in order
to eliminate inactive extracts. The mf were incubated at
37 °C under an atmosphere of 5 % CO2 in humidified air
for 5 days. Mf motility was scored microscopically, daily.
The percentage motility inhibition scores were assigned
as 100 % (all mf immotile), 75 % (only head or tail of mf
shaking, occasionally), 50 % (whole body of mf motile
but sluggishly or with difficulties), 25 % (almost vigorous
motility), 0 % (vigorous motility).
Secondary screens on O. ochengi adult worms and mf
This was done as previously described [11]. Extracts
with 100 % activity on both adult female worms and mf
at primary screens were re-tested at serial dilutions of
eight concentrations (spanning the range of 500 to
3.91 μg/mL), in order to determine the IC50 values using
Cho-Ngwa et al. BMC Complementary and Alternative Medicine  (2016) 16:326 Page 3 of 9
Graphpad prism software, version 6.0 (GraphPad Prism
INC., CA, USA).
Isolation and screens on Loa loa microfilariae
Isolation of Loa loa mf
Ethical clearance (2013/11/371/L/CNERSH/SP) and ad-
ministrative clearance (631–06.14) were obtained from
the Cameroon National Ethical Committee and the Min-
istry of Public health, respectively. Local administrative
clearance was given by the District Medical Officer of
the Edea health district where patients were recruited
for the study. Informed consent was obtained freely from
individuals who tested positive for high L. loa mf load.
Isolation of L. loa mf was done as previously de-
scribed by Gousard et al. [22] but with some modifi-
cations. Freshly collected L. loa -infected blood
(2 mL) was diluted (1:2) with incomplete culture
medium (ICM; i.e., CCM without serum) and care-
fully layered on 4 ml of Ficoll-pacque (TM) in a
15 mL centrifuge tube. The tube was spun in a
swing bucket centrifuge (400×g, 15 min, 25 °C), and
the ficoll layer containing mf recovered and washed
three times with ICM. The mf were re-suspended in
CCM, and then distributed in wells of a 96-well mi-
crotiter plate containing LLC-MK2 cell layers (~15
mf/well/100 μL of CCM). The mfs were monitored
for 24 h for viability and sterility before treatment
with extracts.
Screens on L. loa mf
Only the most active extracts on O. ochengi adult female
worms and mf were screened on L. loa mf. This was
done as in the primary O. ochengi mf screen and at serial
dilutions of 8 concentrations (500–3.91 μg/mL).
Toxicity assessment of extracts
Cytotoxicity assessment of extracts
Cytotoxicity of extracts with good filaricidal activities
were assessed on LLC-MK2 cells on day 5 as part of the
mf secondary screen assays as previously described [11].
The 50 % cytotoxic concentrations (CC50 values) for
these cells were determined by microscopic examination.
Dead or deformed cells were usually detached from the
bottom of the vessel and were rounded in shape. The se-
lectivity index (SI) of each extract was calculated as the
ratio of CC50 of the extract on the mammalian cells to
the IC50 of the extract on the O. ochengi or L. loa
parasite.
Acute toxicity
The acute toxicity was evaluated for the most active ex-
tracts on O. ochengi adult worms and mf in accordance
with the Organisation for Economic Co-operation and
Development (OECD) guidelines for testing chemicals
[23]. Ethical permit was obtained from the University of
Buea, Faculty of Science Institutional Animal Care and
Use Committee (IACUC). Eight nulliparous and non-
pregnant Balb/c mice, ten weeks old (averagely 18 g
each) were divided in four groups (2 per group) and kept
in their cages for 5 days to allow for acclimatization to
the new housing conditions. Three groups were used for
the three most active extracts and the last group as
negative control. Food, but not water was withheld for
4 h after which the animals were weighed and the ex-
tract administered orally using a gavage needle at a limit
dose of 2000 mg/kg body weight with a volume of 1 mL/
100 g body weight of mice. The extracts were diluted
with distilled water prior to administration, while nega-
tive control mice received the vehicle (2 % DMSO di-
luted in distilled water, 200 μL/kg body weight). After
administration of the extracts, food was withheld further
for 2 h. The animals were observed individually after
dosing, once every 30 min during the first 4 h. The ani-
mals were weighed every 2 days and observed for phys-
ical activity and behavioural pattern, food and water
intake, changes in skin and fur, eyes and mucous mem-
branes, tremours, convulsions, salivation, lethargy, sleep,
coma and death for 14 days.
Phytochemical screening
Phytochemical derivatives in the 3 most active extracts
were investigated by standard methods against known
references. The presence of saponins and sterols was de-
termined as described earlier [24]. Saponins were de-
tected by dissolving trace amounts of the extract in
distilled water and shaking thoroughly. Frothing which
persisted on warming was observed and taken as evi-
dence. The presence of steroids was determined by dis-
solving 0.1 g extract in methylene chloride (3 mL) and
acetic anhydride (2 drops). The mixture was boiled and
1 drop of concentrated sulphuric acid added after cool-
ing. A green colour indicated the presence of sterols. For
tannins, 1 g of extract was dissolved in methanol and 2
drops of ferric chloride were added, and the mixture
observed for appearance of an olive green colour
(which is indicative of the presence of tannins) [8].
Alkaloids were tested by thin-layer chromatography
(TLC) on aluminium plates coated with silica gel.
Each extract (0.5 g) was dissolved in methylene chlor-
ide, spotted on the TLC plate, and resolved using a
mobile phase constituted of 20 % hexane/ethylacetate.
Resulting spots were developed by spraying the plate
with Drangedoff ’s reagent, and shiny yellow spots in-
dicated the presence of alkaloids [25]. The presence
of flavonoids was revealed by formation of crimson
red colour when 0.1 g extract is dissolved in metha-
nol with few fragments of magnesium ribbons and 1
drop of concentrated hydrochloric acid [25].
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Statistical analysis
To determine IC50 values of active extracts, the filarici-
dal activity data obtained were analysed using GraphPad
Prism 6.0 (GraphPad Prism INC., CA, USA). The loga-
rithm of the extract concentration was plotted against
its activity determined by microscopy, to obtain a non-
linear regression curve –fitting and a variable slope sig-
moidal dose- response curve.
Results
A total of 14 extracts were prepared from different parts
of the two plants using solvents of different polarities:
hexane followed by methylene chloride and then metha-
nol, sequentially. Generally, the percentage yields of hex-
ane extracts were highest while those of methanol were
lowest (Table 1).
In the primary screens on O. ochengi, at 500 μg/mL,
13 from the 14 extracts showed 100 % activity on adult
male worms and mf while 9 had 100 % activity also on
adult females (Table 2). Since activity on adult female
worm is the most desirable property of an onchocercia-
sis drug, only these 9 extracts were selected for continu-
ation of the study. They were screened at eight
concentrations (500 μg/mL - 3.9 μg/mL) on the O.
ochengi parasite stages, in experiments to determine
IC50 values. The filaricidal activities of each extract
showed a dose dependent response for both adult worms
and mf (Figs. 1a, b and c). IC50 values generated using
GraphPad prism version 6.0 (Graphpad software INC,
USA) are shown in Tables 3 and 4. Of these 9 extracts,
the methylene chloride preparation of P. umbellatum
leaves (PULmc) was the most active on O. ochengi adult
male and female worms, with IC50 values of 16.63 μg/
mL and 35.65 μg/mL, respectively; and 125 μg/mL on
the microfilariae (Table 3). For T. Benthami, only the
hexane extract of the roots (TBRhex) showed 100 % ac-
tivity on the adult female O. ochengi in the primary
screens and did not show very encouraging results in ex-
periments to determine IC50 values (Table 3).
On the mf, the most active extracts were from P.
umbellatum and included hexane extracts from seeds
and roots (PUShex and PURhex, respectively, with IC50
of 31.25 μg/mL for both), as well as methylene chloride
extract from leaves (PULmc IC50 of 32.23 μg/mL). Al-
though PUShex and PURhex had the lowest and similar
IC50 values on the O. ochengi mf (31.25 μg/mL for the 2
extracts), PUShex showed more rapid killing in time-
dependent studies (Fig. 2).
The most active extracts on adult O. ochengi female
worms were PULmc, PURhex and PUShex. These 3 ex-
tracts were further screened on L. loa mf at 8 concentra-
tions (500–3.91 μg/mL) and the IC50 values obtained
were 35.12, 16.12, and 13.90 μg/mL for PULmc, PURhex
and PUShex respectively. All the three extracts were
more active on L. loa mf than O. ochengi mf, with
PUShex showing the lowest IC50 of 13.10 μg/mL on L.
loa mf.
The cytotoxic effects of the interesting extracts were
evaluated on monkey kidney epithelial cells (LLC-MK2)
by microscopy alongside the mf screens. With the excep-
tion of PURmc and PURmet, all the extracts were more
toxic to the O. ochengi female worms than to the cells,
as reflected by their selectivity indices (SI) (Table 3). On
O. ochengi mf, PULmc recorded the highest SI of 2.9
while PURhex, PURmet and PUShex recorded the lowest
SI of 1.5 (Table 3). On adult males, PULmc recorded the
highest SI of 5.6, while PURhex recorded the lowest SI
of 1.1. Finally, on adult females, PULmc also recorded
the highest SI of 2.6 while PURmc recorded the lowest
SI of 0.6 (Table 3).
The 3 most active extracts on O. ochengi adult female
and mf (PULmc, PURhex and PUShex) showed no sign
of acute toxicity to Balb/c mice at a limit dose of
2000 mg/kg body weight when the extracts were given
Table 1 Plant parts and yield of crude extracts obtained with the different solvents
Plant name Plant part (dry weight) Parameter Hexane (hex) extracts Methylene chloride (mc) extracts Methanol (met) extracts
Tragia benthami Leaves (L) (131.05 g) Extract code TBLhex TBLmc TBLmet
Yield (%) 4.20 1.31 0.08
Roots (R) (83.21 g) Extract code TBRhex TBRmc TBRmet
Yield (%) 0.29 0.24 0.60
Piper umbellatum Leaves (L) (75.70 g) Extract code PULhex PULmc PULmet
Yield (%) 2.97 1.78 0.61
Roots (R) (75.70 g) Extract code PURhex PURmc PURmet
Yield (%) 1.88 1.51 0.62
Seeds (S) (33.54 g) Extract code PUShex PUSmc PUSmet
Yield (%) 0.54 01.19 ND
TBL Tragia benthami leaves, TBR Tragia benthami roots, PUL Piper umbellatum leaves, PUR Piper umbellatum roots, PUS Piper umbellatum seeds, hex hexane, mc
methylene chloride, met methanol, ND not done
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Table 2 Mean percent activity of crude extracts on Onchocerca ochengi adult worms and mf in primary screens




Activity on O. ochengi male
(%)
Activity on O. ochengi female
(%)
Activity on O. ochengi mf
(%)
Tragia benthami TBLhex 500 μg/mL 100 91.25 75
TBLmc 500 μg/mL 100 87.5 100
TBLmet 500 μg/mL 100 56.25 100
TBRhex 500 μg/mL 100 100 100
TBRmc 500 μg/mL 100 93.75 100
TBRmet 500 μg/mL 100 12.5 100
Piper unbellatum PULhex 500 μg/mL 100 100 100
PULmc 500 μg/mL 100 100 100
PULmet 500 μg/mL 100 100 100
PURhex 500 μg/mL 100 100 100
PURmc 500 μg/mL 100 100 100
PURmet 500 μg/mL 100 100 100
PUShex 500 μg/mL 100 100 100
PUSmc 500 μg/mL 100 100 100
Negative control NA 2 % DMSO 0 0 0
Auranofin (Positive
control)
NA 10 μM 100 100 100
TBL Tragia benthami leaves, TBR Tragia benthami roots, PUL Piper umbellatum leaves, PUR Piper umbellatum roots, PUS Piper umbellatum seeds, hex hexane, mc
methylene chloride, met methanol, NA not applicable



























































Fig. 1 Dose dependent effect of (a) PULmc on adult O. ochengi male worms; (b) PULmc on adult O. ochengi female worms; (c) PULmc on O.
ochengi microfilariae
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orally and the animals followed-up for 24 h, and 14 days
post-treatment. The average weights of the mice in-
creased from 18 g pre-treatment to 22.7 g post-
treatment. When compared with the control group
treated with vehicle (2 % DMSO dissolved in distilled
water, and given at a dose of 0.2 mL/kg body weight),
there was no significant difference in food and water in-
take. No change was observed in agility, physical appear-
ance and behaviour of the mice 24 h post-treatment.
Likewise, there was no loss of fur as well as no change
in skin and mucous membrane. The test and control
groups were indistinguishable from one another on the
basis of their appearances and physical activity at the
end of the study period (data not shown).
Phytochemical screening of the 3 most active extracts
revealed the presence of saponins, steroids, tannins and
flavonoids (Table 4).
Discussion
The aim of the present study was to assess the activity
of two medicinal plants, T. benthami and P. umbellatum
on O. ochengi and L. loa. Extracts from the plants are lo-
cally used in the North West Region of Cameroon for
the treatment of onchocerciasis. A total of 14 crude ex-
tracts of varying solubilities were prepared from parts of
the plants and tested in previously standardised assays.
Interestingly, 9 of the 14 extracts showed 100 % activity
when screened in vitro at 500 μg/mL against O. ochengi
adult female worms and mf and so were subjected to
lower drug concentration screens, which also showed
promising results with IC50 values reaching down to
16.63 μg/mL.
Previous studies have shown that some Cameroonian
medicinal plants, including Magaritaria discoidea,
Homalium africanum, Craterispermum laurinum, Mor-
inda lucida and Cyperus articulatus also have anti O.
ochengi activity [11–13]. The demonstration of such
good activity by these two plants has come to expand
the list. Additionally, two clear trends have emerged, the
first being the high hit rate of such medicinal plant prep-
arations on the Onchocerca parasites in vitro, and the
second being that extracts from anti-Onchocerca medi-
cinal plants also generally show activity against multiple
pathogens. For example, extracts of P. umbellatum have
shown activity against many coliform bacteria [19], and
has also been used to treat certain physiological or bio-
chemical disorders [17].
Selection of the 9 extracts from the primary screen
data for further studies was mainly based on their good
activities on adult female O. ochengi worms. Activity on
female worm is most important because this is the stage
that produces the microfilariae that generate pathologies
and because from this and previous studies, it is the
most difficult stage to kill with drugs. In these secondary
screens, the extracts showed a dose and time dependent
activity on parasites and the highly active ones on O.
ochengi were PULmc (lowest IC50 of 16.63 μg/mL on
adult males), PURhex (lowest IC50 of 37.36 μg/mL on
adult females) and PUShex (lowest IC50 of 33.26 μg/mL
on adult males) (Table 3). These three extracts were also
very active on L. loa mf. PURhex and PUShex exhibited
higher activity on L. loa mf than on O. ochengi mf (IC50
of 16.12 μg/mL and 13.90 μg/mL versus 31.25 μg/mL
each on O. ochengi mf, respectively). This suggests that
Table 3 IC50 values, CC50s and Selectivity index (SI) values of the O. ochengi adult female hits on the different O. ochengi parasite
stages tested
Extract
Nature of parameter Parameter TBRhex PULhex PULmc PULmet PURhex PURmc PURmet PUShex PUSmc
Inhibition of adult male worm motility IC50 (μg/mL) 131.7 33.26 16.63 31.25 43.22 48.89 34.89 32.82 43.22
CC50 (μg/mL) 375 93.75 93.75 93.73 46.88 93.75 93.75 46.88 46.88
SI 2.8 2.8 5.6 3.0 1.1 1.9 2.7 1.4 1.1
Inhibition of formazan formation by female worms IC50 (μg/mL) 213.5 67.87 35.65 125.30 37.36 162.70 125.30 37.79 37.36
CC50 (μg/mL) 375 93.75 93.75 93.73 46.88 93.75 93.75 46.88 46.88
SI 1.8 1.4 2.6 0.75 1.3 0.6 0.7 1.2 1.3
Inhibition of mf motility IC50 (μg/mL) 154.8 62.50 125.0 31.25 55.61 62.50 31.25 31.25 125.0
CC50 (μg/mL) 375 93.75 93.75 93.73 46.88 93.75 93.75 46.88 46.88
SI 2.4 1.5 2.9 3.0 1.5 1.7 1.5 1.5 1.5
Table 4 Phytochemical analysis of extracts most active on O.
ochengi female worms
Class of compound PULmc PURhex PUShex
Saponins + + −
Sterols +++ + +++
Tanins + + −
Alkaloids − − −
Flavonoids + + +
+++: highly present +: Present; −: Absent.; The extracts codes are PUL mc,
methylene chloride of P. umbellatum leaves, PUR hex hexane extracts of P.
umbellatum roots, PUS hex hexane extract of P. umbellatum seeds
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these two extracts cannot be safely used as phytomedi-
cine to treat onchocerciasis in individuals with high L.
loa mf load, as this may lead to the severe adverse reac-
tion previously reported [5]. However, PULmc exhibited
slightly less, but similar activity on L. loa and O. ochengi
mf (IC50 values of 35.12 μg/mL versus 32.13 μg/mL, re-
spectively). Further fractionation or isolation of com-
pounds from the extracts is recommended since this
may result in some degree of resolution of anti-Oncho-
cerca and anti-L. loa components, leading to the elimin-
ation of compounds that selectively kill the L. loa mf.
After investigating the filaricidal activity of the ex-
tracts, it was necessary to investigate their safety. This
was done by evaluating cytotoxicity on LLC-MK2 cells
for the 9 extracts that were active on female worms, and
acute toxicity in Balb/c mice for the 3 most active ex-
tracts, which were part of the 9 female hits. With the ex-
ception of PURmc and PURmet, all the extracts tested
were more toxic to the O. ochengi worm stages than to
cells, as reflected by their SIs (Table 3). The safest ex-
tract, PULmc, recorded the highest selectivity indices of
5.6, 2.6 and 2.9 for O. ochengi adult male, adult female
and mf, respectively. A starting point of 5.6 is good
enough to encourage further refinement of an extract or
development of an active principle contained there in.
When tested for toxicity in vivo, all 3 most active ex-
tracts (PULmc, PURhex and PUShex) showed no sign of
acute toxicity to Balb/c mice. This suggests that these 3
extracts could be safely used in phytomedicines for on-
chocerciasis treatment in areas where L. loa is not preva-
lent, and justifies their popular use in traditional
medicine in the North West Region of Cameroon as
anti-Onchocerca remedies. Worth noting is the fact that
toxic and mutagenic concentrations of different sub-
stances could differ greatly between cells from human
and other species, indicating that results of such studies
cannot always be extrapolated from animal to human
situations [26].
Pharmacological potential of plants is attributed to
presence of wide array of phytochemical compounds in
them [27, 28]. Therefore, in current study an effort was
made to explore potential active ingredients from the
studied extracts. The phytochemical screening of the
three promising extracts revealed the presence of ste-
roids, flavanoids, and tannins/saponins (Table 4), sug-
gesting that active principles in the extracts may be from
the aforementioned groups of compounds. This corrobo-
rates previous findings in which microfilaricidal extracts
(activity against O. ochengi mfs) from Margaritaria dis-
coidea and Homalium africanum contained sterols and
terpenoids [11]. An extract from Annona senegalensis,
which inhibited survival of O. ochengi adult worms, was
reported to be rich in saponins, tannins and flavonoids
[29]. Also, the presence of sterols, saponins, and/or fla-
vonoids was reported in the fractions from Craterisper-
mum laurinum and Morinda lucida which were active
on O. ochengi adult worms in vitro [13]. Likewise, crude
extracts of Artemisia annua were shown to possess a
plethora of other compounds including flavonoids,
which enhance the in vitro activity of artemisinin against
the parasite Plasmodium falciparum [10].
Conclusion
In order to assess the anti-filarial properties of Piper
umbellatum L. and Tragia benthami B., a total of 14 ex-
tracts were prepared from the plants and screened
in vitro against Onchocerca ochengi parasite and L. loa
microfilariae. Cytotoxicity and acute toxicity of active
extracts were tested on monkey kidney cells and Balb/c
mice, respectively. The three most active extracts on
Fig. 2 Time dependent killing of O. ochengi microfilariae by most active extracts at their IC100 concentrations
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Onchocerca ochengi females were also highly active on
Loa loa microfilariae, with IC50s of 35.12 - 13.9 μg/mL.
Overall, results from this study suggests that crude ex-
tracts of different polarities of P. umbellatum and T.
benthami exhibit selective filaricidal activity and could
serve as potential sources of new drugs against oncho-
cerciasis. It also validates the traditional use of these
plants in the treatment of onchocerciasis.
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